Axogen Corporation

13631 Progress Blvd Ste 400, Alachua, Florida, United States

Also known as:

axogen nerve regeneration

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

40.0%

Phase 4

20.0%

Phase 3

10.0%

Trial Status Distribution

Active, not recruiting

30.0%

Completed

30.0%

Recruiting

10.0%

Terminated

30.0%

Clinical Trials

Trials sponsored by this organization (10)

A Prospective, Randomized, Assessor-Blinded, Multicenter Study Comparing Avance Nerve Graft and Autograft for Functional Recovery Following Mixed and Motor Peripheral Nerve Reconstruction

Phase 4

Recruiting

interventional

Jun 2026178 participants

Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression

Not Applicable

Active, not recruiting

interventional

Oct 202320 participants

Tolerability and Feasibility Pilot Clinical Study of a Large-Diameter Nerve Cap for Protecting and Preserving Terminated Nerve Ends

Not Applicable

Active, not recruiting

interventional

Mar 202215 participants

Surgical Treatment of Chronic Neuropathic Pain

Terminated

observational

Feb 20208 participants

Registry of Avive® Soft Tissue Membrane Utilization in Selected Applications of Acute Trauma of the Upper Extremity

Terminated

observational

Dec 20187 participants

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

Not Applicable

Completed

interventional

Oct 201886 participants

Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve Repair

Phase 3

Completed

interventional

Jun 2015220 participants

Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

Phase 4

Completed

interventional

Aug 200912 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

Avance Nerve Graft

FDA

2026-01-23

News

No news articles found

Back to Organizations